Literature DB >> 21884699

High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and Receptor for Advanced Glycation End Products.

Andréy Mazarati1, Mattia Maroso, Valentina Iori, Annamaria Vezzani, Mirjana Carli.   

Abstract

High-mobility group box-1 (HMGB1) is a nuclear protein with cytokine-type functions upon its extracellular release. HMGB1 activates inflammatory pathways by stimulating multiple receptors, chiefly toll-like receptor 4 (TLR4) and Receptor for Advanced Glycation End Products (RAGE). TLR4 and RAGE activation has been implicated in memory impairments, although the endogenous ligand subserving these effects is unknown. We examined whether HMGB1 induced memory deficits using novel object recognition test, and which of the two receptor pathways was involved in these effects. Non-spatial long-term memory was examined in wild type, TLR4 knockout, and RAGE knockout mice. Recombinant HMGB1 (10μg, intracerebroventricularly, i.c.v.) disrupted memory encoding equipotently in wild type, TLR4 knockout and RAGE knockout animals, but affected neither memory consolidation, nor retrieval. Neither TLR4 knockout nor RAGE knockout mice per se, exhibited memory deficits. Blockade of TLR4 in RAGE knockout mice using Rhodobacter sphaeroides lipopolysaccharide (LPS-Rs; 20 μg, i.c.v.) prevented the detrimental effect of HMGB1 on memory. These data show that elevated brain levels of HMGB1 induce memory abnormalities which may be mediated by either TLR4, or RAGE. This mechanism may contribute to memory deficits under various neurological and psychiatric conditions associated with the increased HMGB1 levels, such as epilepsy, Alzheimer's disease and stroke.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21884699      PMCID: PMC3202022          DOI: 10.1016/j.expneurol.2011.08.012

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  63 in total

1.  Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease.

Authors:  C A McLean; R A Cherny; F W Fraser; S J Fuller; M J Smith; K Beyreuther; A I Bush; C L Masters
Journal:  Ann Neurol       Date:  1999-12       Impact factor: 10.422

Review 2.  Retrieval and reconsolidation: toward a neurobiology of remembering.

Authors:  S J Sara
Journal:  Learn Mem       Date:  2000 Mar-Apr       Impact factor: 2.460

Review 3.  Molecular neurobiology of human cognition.

Authors:  Edwin J Weeber; J David Sweatt
Journal:  Neuron       Date:  2002-03-14       Impact factor: 17.173

4.  Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion.

Authors:  Tiziana Bonaldi; Fabio Talamo; Paola Scaffidi; Denise Ferrera; Annalisa Porto; Angela Bachi; Anna Rubartelli; Alessandra Agresti; Marco E Bianchi
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

Review 5.  The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications.

Authors:  Jennifer M Loftis; Aaron Janowsky
Journal:  Pharmacol Ther       Date:  2003-01       Impact factor: 12.310

6.  Diphosphoryl lipid A from Rhodobacter sphaeroides blocks the binding and internalization of lipopolysaccharide in RAW 264.7 cells.

Authors:  G D Kutuzova; R M Albrecht; C M Erickson; N Qureshi
Journal:  J Immunol       Date:  2001-07-01       Impact factor: 5.422

7.  RO-10-5824 is a selective dopamine D4 receptor agonist that increases novel object exploration in C57 mice.

Authors:  Susan B Powell; Martin P Paulus; Deborah S Hartman; Thierry Godel; Mark A Geyer
Journal:  Neuropharmacology       Date:  2003-03       Impact factor: 5.250

8.  RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease.

Authors:  Fang Fang; Lih-Fen Lue; Shiqiang Yan; Hongwei Xu; John S Luddy; Doris Chen; Douglas G Walker; David M Stern; Shifang Yan; Ann Marie Schmidt; John X Chen; Shirley ShiDu Yan
Journal:  FASEB J       Date:  2009-11-11       Impact factor: 5.191

9.  Altered expression of novel genes in the cerebral cortex following experimental brain injury.

Authors:  Nobuhide Kobori; Guy L Clifton; Pramod Dash
Journal:  Brain Res Mol Brain Res       Date:  2002-08-15

10.  Release of chromatin protein HMGB1 by necrotic cells triggers inflammation.

Authors:  Paola Scaffidi; Tom Misteli; Marco E Bianchi
Journal:  Nature       Date:  2002-07-11       Impact factor: 49.962

View more
  64 in total

Review 1.  Immunity and inflammation in status epilepticus and its sequelae: possibilities for therapeutic application.

Authors:  Annamaria Vezzani; Raymond Dingledine; Andrea O Rossetti
Journal:  Expert Rev Neurother       Date:  2015       Impact factor: 4.618

2.  The alarmin HMGB-1 influences healing outcomes in fetal skin wounds.

Authors:  Adrienne D Dardenne; Brian C Wulff; Traci A Wilgus
Journal:  Wound Repair Regen       Date:  2013-02-25       Impact factor: 3.617

Review 3.  Inflammation in Epileptic Encephalopathies.

Authors:  Oleksii Shandra; Solomon L Moshé; Aristea S Galanopoulou
Journal:  Adv Protein Chem Struct Biol       Date:  2017-02-28       Impact factor: 3.507

4.  Neuroinflammation Alters Integrative Properties of Rat Hippocampal Pyramidal Cells.

Authors:  Federica Frigerio; Corey Flynn; Ye Han; Kyle Lyman; Joaquin N Lugo; Teresa Ravizza; Antoine Ghestem; Julika Pitsch; Albert Becker; Anne E Anderson; Annamaria Vezzani; Dane Chetkovich; Christophe Bernard
Journal:  Mol Neurobiol       Date:  2018-02-09       Impact factor: 5.590

5.  Preclinical models of overwhelming sepsis implicate the neural system that encodes contextual fear memory.

Authors:  Patricio T Huerta; Sergio Robbiati; Tomás Salvador Huerta; Anchal Sabharwal; Rose A Berlin; Maya Frankfurt; Bruce T Volpe
Journal:  Mol Med       Date:  2016-11-17       Impact factor: 6.354

6.  HMGB1 Mediates Paraquat-Induced Neuroinflammatory Responses via Activating RAGE Signaling Pathway.

Authors:  Min Huang; Muzhen Guo; Kai Wang; Kexin Wu; Yingying Li; Tian Tian; Yifan Wang; Weiguang Yan; Zhijun Zhou; Huifang Yang
Journal:  Neurotox Res       Date:  2019-12-20       Impact factor: 3.911

7.  Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy.

Authors:  Alberto Pauletti; Gaetano Terrone; Tawfeeq Shekh-Ahmad; Alessia Salamone; Teresa Ravizza; Massimo Rizzi; Anna Pastore; Rosaria Pascente; Li-Ping Liang; Bianca R Villa; Silvia Balosso; Andrey Y Abramov; Erwin A van Vliet; Ennio Del Giudice; Eleonora Aronica; Manisha Patel; Matthew C Walker; Annamaria Vezzani
Journal:  Brain       Date:  2019-07-01       Impact factor: 13.501

Review 8.  Biomarkers of Epileptogenesis: The Focus on Glia and Cognitive Dysfunctions.

Authors:  Annamaria Vezzani; Rosaria Pascente; Teresa Ravizza
Journal:  Neurochem Res       Date:  2017-04-22       Impact factor: 3.996

9.  High mobility group box 1/Toll-like receptor danger signaling increases brain neuroimmune activation in alcohol dependence.

Authors:  Fulton T Crews; Liya Qin; Donna Sheedy; Ryan P Vetreno; Jian Zou
Journal:  Biol Psychiatry       Date:  2012-12-01       Impact factor: 13.382

Review 10.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.